Two independent alleles at 6q23 associated with risk of rheumatoid arthritis

Robert M. Plenge(Broad Institute), David Altshuler(Vertex Pharmaceuticals (United States)), Robert Graham(GenProMarkers (United States)), Itsik Pe’er(Columbia University), Brendan Blumenstiel(Broad Institute), Elena S. Izmailova(Millennium Engineering and Integration (United States)), Benjamin M. Neale, Matt DeFelice(Broad Institute), Leonid Padyukov(Karolinska University Hospital), Julian Maller(Broad Institute), Roberta Glass(Brigham and Women's Hospital), Rachel Barry(Broad Institute), Elaine F. Remmers(National Institutes of Health), Annette T. Lee(Northwell Health), Alexander N. Parker(Millennium Engineering and Integration (United States)), Michael E. Weinblatt(Brigham and Women's Hospital), Shaun Purcell(Broad Institute), Ronenn Roubenoff(Millennium Engineering and Integration (United States)), Stacey Gabriel(Broad Institute), Melissa Parkin(Broad Institute), Paul I. W. de Bakker(Broad Institute), Alkes L. Price(Broad Institute), Lars Alfredsson(Karolinska Institutet), Lars Klareskog(Karolinska University Hospital), Claire M. Healy(Broad Institute), Leela Davies, Nancy A. Shadick(Brigham and Women's Hospital), Peter K. Gregersen(Northwell Health), Wendy Winslow(Broad Institute), Chris Cotsapas(Amicus Therapeutics (United Kingdom)), Mark J. Daly(Broad Institute), Noël P. Burtt(Broad Institute), Jonathan Coblyn(Brigham and Women's Hospital), Nancy Maher(Brigham and Women's Hospital), Elizabeth W. Karlson(ENT and Allergy), David A. Hafler(Yale University), Michael F. Seldin(University of California, Davis), David M. Lee(Brigham and Women's Hospital)
Nature Genetics
November 4, 2007
Cited by 550


Related Papers